Lipid Management in Patients with Endocrine Disorders

Publication Date: September 19, 2020
Last Updated: March 16, 2022


1. Screening and Cardiovascular Disease Risk Assessment

Measurement of Lipids

1.1 In adults with endocrine disorders, we recommend a lipid panel for the assessment of TG levels and for calculating LDL-C. Technical Remarks:
  • Non-fasting lipid panels are acceptable for initial screening.
  • If TG levels are elevated or if genetic dyslipidemia is suspected, repeat a fasting lipid panel.
  • If lipoprotein(a) [Lp(a)] levels are measured, fasting or non-fasting samples can be obtained.


2. Hypertriglyceridemia

2.1 In adults with fasting TG levels over 500 mg/dL (5.6 mmol/L), we recommend pharmacologic treatment as adjunct to diet and exercise to prevent pancreatitis. ()

Technical Remark:

  • Patients with TG levels over 1000 mg/dL (11.3 mmol/L) often do not get an adequate response to medications and therefore, control of diabetes, modification of diet, and weight loss are essential.



Lipid Management in Patients with Endocrine Disorders

Authoring Organization